HPVC2019-159: Biopharmaceuticals Long-Acting Granulocyte-Colony Stimulating Factor

Current Contract

Contract start date: 28 Jun 2019

Contract end date: 29 Jan 2026

Option periods: Nil

Description

Contract for the provision of long acting granulocyte colony-stimulating factor (G-CSF) to Victorian public hospitals and health services.

Additional information

Contract Details

The Principal Period (2 years) commenced on 28 June 2019 until 27 June 2021. 

The first Contract Option period of two years has been executed - effective from 28 June 2021 until 27 June 2023.

The second Contract Option period of two years has been executed – effective from 28 June 2023 until 27 June 2025.

Contract has been extended - effective 28 June 2025 until 29 January 2026.

Option Periods Remaining

Nil.

Categories

Category 1: Biopharmaceuticals Long-Acting Granulocyte Colony-Stimulating Factor

Categories

1. Long-Acting Granulocyte Colony-Stimulating Factor